Elimination of the DEA DATA-waiver requirement

The Drug Enforcement Administration has made our organization aware that they have eliminated the requirement for DATA-waiver registration for professionals to prescribe buprenorphine to treat opioid use disorder. The DEA stated, "On December 29, 2022, with the signing of the Consolidated Appropriations Act of 2023 (the Act), Congress eliminated the 'DATA-Waiver Program.'